Symbols

CLOV

Clover Health·NASDAQ

--(--)

Signals Analysis

Bullish signal 2

Bearish signal 2

High Gross Profit Margin

Significant Net Income Decline

Revenue Beats Expectation

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About CLOV

Clover Health Investments, Corp.

A company that provides Medicare Advantage insurance plans and operates as a direct contracting entity with the U.S. government

Industry

Insurance

Established Date

10/18/2019

Listing Date

01/08/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

724

Fiscal Year Ends

12-31

Website

www.cloverhealth.com

Security Type

Common stock

Office address

3401 Mallory Lane, Suite 210, Franklin, Tennessee 37067

Business

Introduction

Clover Health Investments, Corp. was incorporated in the Cayman Islands on October 18, 2019. The company's goal is to empower physicians through technology to identify, manage and treat chronic diseases earlier, ultimately leading to better healthcare outcomes for Medicare Advantage (" MA ") members. Clover Health's strategy includes developing an extensive network of physicians and providing a proprietary software platform called Clover Assistant that supports real-time clinical decision-making by providing physicians with data and insights. This cloud-based platform aggregates information from more than 100 sources to provide personalized care advice. Clover Health utilizes Clover Assistant in its Preferred Provider Organization (" OPPO ") and Health Maintenance Organization (" HMO ") programs to provide affordable, high-quality healthcare while maintaining low average out-of-pocket costs for its members.

Company Financials

EPS

CLOV has released its 2025 Q4 earnings. EPS was reported at -0.1, versus the expected -0.1, meeting expectations. The chart below visualizes how CLOV has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

CLOV has released its 2025 Q4 earnings report, with revenue of 487.71M, reflecting a YoY change of 44.74%, and net profit of -49.32M, showing a YoY change of -123.25%. The Sankey diagram below clearly presents CLOV's revenue sources and cost distribution.